Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
- PMID: 23714073
- DOI: 10.1016/j.bbr.2013.05.027
Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
Abstract
Anandamide and 2-arachidonoylglycerol (2-AG) are the two main endocannabinoids, exerting their effects by activating type 1 (CB1r) and type 2 (CB2r) cannabinoid receptors. Anandamide inhibits anxiety-like responses through the activation of CB1r in certain brain regions, including the dorsolateral periaqueductal gray (dlPAG). 2-AG also attenuates anxiety-like responses, although the neuroanatomical sites for these effects remained unclear. Here, we tested the hypothesis that enhancing 2-AG signaling in the dlPAG would induce anxiolytic-like effects. The mechanisms involved were also investigated. Male Wistar rats received intra-dlPAG injections of 2-AG, URB602 (inhibitor of the 2-AG hydrolyzing enzyme, mono-acylglycerol lipase--MGL), AM251 (CB1r antagonist) and AM630 (CB2r antagonist). The behavior was analyzed in the elevated plus maze after the following treatments. Exp. 1: vehicle (veh) or 2-AG (5 pmol, 50 pmol, and 500 pmol). Exp. 2: veh or URB602 (30 pmol, 100 pmol or 300 pmol). Exp. 3: veh or AM251 (100 pmol) followed by veh or 2-AG (50 pmol). Exp. 4: veh or AM630 (1000 pmol) followed by veh or 2-AG. Exp. 5: veh or AM251 followed by veh or URB602 (100 pmol). Exp. 6: veh or AM630 followed by veh or URB602. 2-AG (50 pmol) and URB602 (100 pmol) significantly increased the exploration of the open arms of the apparatus, indicating an anxiolytic-like effect. These behavioral responses were prevented by CB1r (AM251) or CB2r (AM630) antagonists. Our results showed that the augmentation of 2-AG levels in the dlPAG induces anxiolytic-like effects. The mechanism seems to involve both CB1r and CB2r receptors.
Keywords: 2-Arachidonoylglycerol (2-AG); Anxiety; Dorsolateral periaqueductal gray; Elevated plus maze; Endocannabinoids.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey.Eur Neuropsychopharmacol. 2016 Jan;26(1):15-22. doi: 10.1016/j.euroneuro.2015.11.014. Epub 2015 Nov 25. Eur Neuropsychopharmacol. 2016. PMID: 26628106
-
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.Neuropharmacology. 2013 Dec;75:86-94. doi: 10.1016/j.neuropharm.2013.07.008. Epub 2013 Jul 27. Neuropharmacology. 2013. PMID: 23899460
-
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.Neuropharmacology. 2007 Mar;52(3):958-65. doi: 10.1016/j.neuropharm.2006.10.013. Epub 2006 Dec 5. Neuropharmacology. 2007. PMID: 17156799
-
[Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system].Postepy Hig Med Dosw (Online). 2014 Jun 12;68:814-27. doi: 10.5604/17322693.1108875. Postepy Hig Med Dosw (Online). 2014. PMID: 24934539 Review. Polish.
-
[2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand].Seikagaku. 2007 Jul;79(7):655-68. Seikagaku. 2007. PMID: 17763698 Review. Japanese. No abstract available.
Cited by
-
A Sexually Dimorphic Role for Intestinal Cannabinoid Receptor Subtype-1 in the Behavioral Expression of Anxiety.Cannabis Cannabinoid Res. 2023 Dec;8(6):1045-1059. doi: 10.1089/can.2023.0150. Epub 2023 Oct 20. Cannabis Cannabinoid Res. 2023. PMID: 37862126 Free PMC article.
-
Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress.J Pain. 2015 Aug;16(8):707-16. doi: 10.1016/j.jpain.2015.04.007. Epub 2015 May 7. J Pain. 2015. PMID: 25958314 Free PMC article.
-
Repeated Mild Traumatic Brain Injury and JZL184 Produce Sex-Specific Increases in Anxiety-Like Behavior and Alcohol Consumption in Wistar Rats.J Neurotrauma. 2023 Nov;40(21-22):2427-2441. doi: 10.1089/neu.2023.0088. Epub 2023 Sep 12. J Neurotrauma. 2023. PMID: 37503666 Free PMC article.
-
Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.J Pharmacol Exp Ther. 2017 Dec;363(3):314-323. doi: 10.1124/jpet.117.244392. Epub 2017 Sep 25. J Pharmacol Exp Ther. 2017. PMID: 28947487 Free PMC article.
-
Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine.Cells. 2021 Sep 26;10(10):2543. doi: 10.3390/cells10102543. Cells. 2021. PMID: 34685523 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical